Can Wegovy Make You Lose Your Hair?

Telogen effluvium (a temporary, stress-related hair-shedding) is the most likely mechanism, not a direct drug effect on follicles.
Hair shedding linked to rapid weight loss typically peaks around three to six months after treatment starts, then gradually resolves.
Nutritional gaps (particularly protein) during a reduced-calorie period can worsen shedding; diet quality alongside treatment matters.
Hair loss is listed as an uncommon side effect in the Wegovy prescribing information, meaning it affects fewer than one in ten people who take it.

Hair loss can happen during significant weight loss on Wegovy, but the medicine itself is rarely the direct cause. What most people experience is a temporary, well-recognised condition called telogen effluvium — triggered by the metabolic stress of rapid weight change rather than semaglutide acting on hair follicles. It nearly always reverses on its own. That said, these are prescription-only medicines, and a prescriber looks at your full picture before treatment begins. For a closer look at the evidence and what to watch for, read on.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The science behind hair changes on Wegovy, and what you can do about them

You notice more hair in the shower three months into treatment (here's what's likely happening

The scenario plays out fairly consistently: treatment starts, appetite falls, the scales move, and then) around the twelve-week mark — there's noticeably more hair on the pillow or blocking the drain. It can be alarming. The instinct is to blame the injection.

What's more probably going on is telogen effluvium, a recognised response to physical stress on the body. Hair follicles cycle through growth and rest phases. When the body experiences a significant metabolic shift (rapid calorie reduction, accelerated weight loss, or the physiological upheaval that follows) a larger proportion of follicles slip prematurely into the resting (telogen) phase. Two to four months later, those hairs shed simultaneously. The timing is what makes it feel sudden.

This pattern has been observed with other weight-loss approaches too, including bariatric surgery, very low calorie diets, and illness-related weight loss. Wegovy's active ingredient, semaglutide, reduces appetite substantially, so the calorie deficit can be steeper than people anticipate, which may make the effect more noticeable than with slower approaches. The NHS medicines page for semaglutide lists hair loss as an uncommon side effect (occurring in fewer than one in ten people), consistent with what clinical trials reported.

The reassuring part: telogen effluvium is temporary. Most people see shedding taper off within six months, and regrowth follows once the body stabilises at its new weight.

Could nutrition be making hair loss worse?

Rapid weight loss, particularly if protein intake drops, creates conditions where hair struggles. Hair is largely keratin (a protein) and follicles are metabolically demanding. When overall calorie intake falls sharply, the body prioritises essential functions. Hair growth is not one of them.

This is worth taking seriously if you're on Wegovy and noticing shedding. Several specific gaps have been associated with accelerated hair loss in people losing weight quickly: inadequate protein (the most commonly implicated), low iron, low zinc, and biotin deficiency, though biotin supplementation is only useful if you're genuinely deficient. General supplementation without a deficiency isn't supported by strong evidence.

Practical steps that can help: keep protein intake up even when appetite is reduced (prioritising it at each meal rather than relying on volume), stay hydrated, and speak to your prescriber if you're concerned, blood tests can identify genuine nutritional deficiencies. Our guide on protein-rich foods alongside semaglutide covers practical diet choices that work with, rather than against, your treatment.

There's also a question of whether the hair loss a person notices is something else entirely. Thyroid conditions, iron-deficiency anaemia, and hormonal changes can all cause similar shedding patterns independently, and may coincide with starting treatment. A GP or dermatologist can help distinguish between causes. Worth checking rather than assuming.

When to tell your prescriber, and when this resolves itself

Most hair shedding in this context settles without intervention. Once weight stabilises, follicles return to their normal cycle, and regrowth (while it can take six to twelve months to become visible) does occur for most people.

Tell your prescriber if: shedding is severe, is getting worse rather than better after six months, is accompanied by fatigue, sensitivity to cold, or other symptoms that suggest a thyroid or nutritional issue, or if it's causing significant distress. These are situations where further investigation is appropriate rather than simply waiting.

There's a broader question some people ask, whether the hair impact is reason to stop treatment. That's genuinely a clinical decision, not one to make alone. The benefits of sustained weight loss on cardiovascular risk, blood pressure, sleep apnoea, and joint health are well-evidenced, and temporary hair shedding has to be weighed alongside that. Our full Wegovy treatment page covers what the medicine involves in practice, including what's included in a private prescription.

It's also worth knowing that long-term hair thinning is a different question from the short-term shedding burst, the evidence points clearly toward the latter being more common. And if you've already started researching and want to compare experiences or evidence across similar questions, the full picture on hair loss and Wegovy and semaglutide's role specifically may be useful reading. For the broader context on hair and weight-loss medicines, our semaglutide and hair page covers the topic in detail.

If you're thinking about starting treatment, a prescriber reviews your medical history, current medicines, and individual situation before anything is prescribed. You can check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber, not software.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions